ADORA2A gene variation, caffeine, and emotional processing: A multi-level interaction on startle reflex

Neuropsychopharmacology

Volumn 37, Issue 3, 2012, Pages 759-769

  Domschke, Katharina ^a   Gajewska, Agnieszka ^b   Winter, Bernward ^a   Herrmann, Martin J ^b   Warrings, Bodo ^b   Mühlberger, Andreas ^b   Wosnitza, Katherina ^a   Glotzbach, Evelyn ^b   Conzelmann, Annette ^b   Dlugos, Andrea ^a   Fobker, Manfred ^a   Jacob, Christian ^b   Arolt, Volker ^a   Reif, Andreas ^b   Pauli, Paul ^b   Zwanzger, Peter ^a   Deckert, Jürgen ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

adenosine; ADORA2A; caffeine; emotional processing; panic disorder; startle

Indexed keywords

ADENOSINE A2A RECEPTOR; CAFFEINE;

ADORA 2A GENE; ADULT; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EMOTIONALITY; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STARTLE REFLEX;

ADULT; ANXIETY; CAFFEINE; DOUBLE-BLIND METHOD; EMOTIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ADENOSINE A2A; SEX FACTORS; STARTLE REACTION;

EID: 84855898245     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.253     Document Type: Article

References (97)

1. Albani C, Blaser G, Geyer M, Schmutzer G, Brahler E, Bailer H et al (2005). [The German short version of 'Profile of Mood States' (POMS): psychometric evaluation in a representative sample]. Psychother Psychosom Med Psychol 55:324-330. (Pubitemid 40979992)
2. Alpers GW, Pauli P (2002). Angstsensitivitäts-Index. PsychScience: Würzburg.
3. Alsene K, Deckert J, Sand P, de Wit H (2003). Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28:1694-1702. (Pubitemid 41070870)
4. Andrews SE, Blumenthal TD, Flaten MA (1998). Effects of caffeine and caffeine-associated stimuli on the human startle eyeblink reflex. Pharmacol Biochem Behav 59:39-44. (Pubitemid 28053677)
5. Armbruster D, Mueller A, Strobel A, Kirschbaum C, Lesch KP, Brocke B (2010). Influence of functional tryptophan hydroxylase 2 gene variation and sex on the startle response in children, young adults, and older adults. Biol Psychol 83:214-221.
6. Bernat E, Patrick CJ, Benning SD, Tellegen A (2006). Effects of picture content and intensity on affective physiological response. Psychophysiology 43:93-103.
7. Bhattacharya SK, Satyan KS, Chakrabarti A (1997). Anxiogenic action of caffeine: an experimental study in rats. J Psychopharmacol 11:219-224. (Pubitemid 27375877)
8. Biehl B, Dangel S, Reiser A (1986). Profile of mood states. In: CIPS (ed). Internationale Skalen für Psychiatrie. Beltz: Weinberg.
9. Blumenthal TD, Cuthbert BN, Filion DL, Hackley S, Lipp OV, van Boxtel A (2005). Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42:1-15. (Pubitemid 40395410)
10. Botella P, Parra A (2003). Coffee increases state anxiety in males but not in females. Hum Psychopharmacol 18:141-143. (Pubitemid 36304729)
11. Boulenger JP, Uhde TW, Wolff III EA, Post RM (1984). Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence. Arch Gen Psychiatry 41:1067-1071. (Pubitemid 14017418)
12. Bradley SJ (2001). Anxiety and mood disorders in children and adolescents: a practice update. Paediatr Child Health 6:459-463. (Pubitemid 33064055)
13. Bruce M, Scott N, Shine P, Lader M (1992). Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry 49:867-869.
14. Bruce MS, Lader M (1989). Caffeine abstention in the management of anxiety disorders. Psychol Med 19:211-214. (Pubitemid 19100281)
15. Butler RW, Braff DL, Rausch JL, Jenkins MA, Sprock J, Geyer MA (1990). Physiological evidence of exaggerated startle response in a subgroup of Vietnam veterans with combat-related PTSD. Am J Psychiatry 147:1308-1312. (Pubitemid 20346267)
16. Charney DS, Heninger GR, Jatlow PI (1985). Increased anxiogenic effects of caffeine in panic disorders. Arch Gen Psychiatry 42:233-243. (Pubitemid 15016112)
17. Childs E, Hohoff C, Deckert J, Xu K, Badner J, de Wit H (2008). Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33:2791-2800.
18. Cook III EW, Davis TL, Hawk LW, Spence EL, Gautier CH (1992). Fearfulness and startle potentiation during aversive visual stimuli. Psychophysiology 29:633-645.
19. Cornelis MC, El-Sohemy A, Campos H (2007). Genetic polymorphism of the adenosine A2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr 86:240-244. (Pubitemid 47041616)
20. de la Mora MP, Gallegos-Cari A, Arizmendi-García Y, Marcellino D, Fuxe K (2010). Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol 90:198-216.
21. Deci PA, Lydiard RB, Santos AB, Arana GW (1992). Oral contraceptives and panic disorder. J Clin Psychiatry 53:163-165.
22. Deckert J (1998). The adenosine A (2A) receptor knockout mouse: a model for anxiety? Int J Neuropsychopharmacol 1:187-190. (Pubitemid 128538378)
23. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D et al (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624. (Pubitemid 29139976)
24. Deckert J, Nothen MM, Franke P, Delmo C, Fritze J, Knapp M et al (1998). Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3:81-85. (Pubitemid 28045190)
25. Domschke K, Braun M, Ohrmann P, Suslow T, Kugel H, Bauer J et al (2006). Association of the functional-1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 9:349-355. (Pubitemid 43780503)
26. Domschke K, Dannlowski U (2010). Imaging genetics of anxiety disorders. Neuroimage 53:822-831.
27. Domschke K, Deckert J, O'Donovan MC, Glatt SJ (2007). Metaanalysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 144 B: 667-673. (Pubitemid 47077152)
28. Domschke K, Freitag CM, Kuhlenbaumer G, Schirmacher A, Sand P, Nyhuis P et al (2004). Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int J Neuropsychopharmacol 7:183-188. (Pubitemid 38823286)
29. Domschke K, Hohoff C, Jacob C, Maier W, Fritze J, Bandelow B et al (2008a). Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. Am J Med Genet B Neuropsychiatr Genet 147 B: 510-516. (Pubitemid 351830814)
30. Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V et al (2008). MAO-A variant influences antidepressant treatment response in female patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 32:224-228.
31. Domschke K, Ohrmann P, Braun M, Suslow T, Bauer J, Hohoff C et al (2008b). Influence of the catechol-O-methyltransferase val158met genotype on amygdala and prefrontal cortex emotional processing in panic disorder. Psychiatry Res 163:13-20.
32. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J et al (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12:205-216. (Pubitemid 36204418)
33. Etkin A (2010). Functional neuroanatomy of anxiety: a neural circuit perspective. Curr Top Behav Neurosci 2:251-277.
34. Evans SM, Griffiths RR (1991). Dose-related caffeine discrimination in normal volunteers: individual differences in subjective effects and self-reported cues. Behav Pharmacol 2:345-356.
35. Filion DL, Dawson ME, Schell AM (1998). The psychological significance of human startle eyeblink modification: a review. Biol Psychol 47:1-43. (Pubitemid 28055136)
36. Fisher S, Guillet R (1997). Neonatal caffeine alters passive avoidance retention in rats in an age-and gender-related manner. Brain Res Dev Brain Res 98:145-149. (Pubitemid 27033663)
37. Flint J, Munafo MR (2007). The endophenotype concept in psychiatric genetics. Psychol Med 37:163-180. (Pubitemid 46158160)
38. Freitag CM, Agelopoulos K, Huy E, Rothermundt M, Krakowitzky P, Meyer J et al (2010). Adenosine A (2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder. Eur Child Adolesc Psychiatry 19:67-74.
39. Fuxe K, Ferre S, Genedani S, Franco R, Agnati LF (2007). Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 92:210-217. (Pubitemid 47381380)
40. Giakoumaki SG, Roussos P, Bitsios P (2008). Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism. Neuropsychopharmacology 33:3058-3068.
41. Gottesman II, Gould TD (2003). The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636-645. (Pubitemid 41079594)
42. Griffiths RR, Woodson PP (1988). Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology (Berl) 94:437-451. (Pubitemid 18087391)
43. Grillon C (2002). Startle reactivity and anxiety disorders: aversive conditioning, context, and neurobiology. Biol Psychiatry 52:958-975. (Pubitemid 35356354)
44. Grillon C (2008). Models and mechanisms of anxiety: evidence from startle studies. Psychopharmacology (Berl) 199:421-437.
45. Grillon C, Ameli R, Goddard A, Woods SW, Davis M (1994). Baseline and fear-potentiated startle in panic disorder patients. Biol Psychiatry 35:431-439. (Pubitemid 24122324)
46. Grillon C, Baas J (2003). A review of the modulation of the startle reflex by affective states and its application in psychiatry. Clin Neurophysiol 114:1557-1579. (Pubitemid 37025791)
47. Grillon C, Morgan III CA, Davis M, Southwick SM (1998). Effects of experimental context and explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress disorder. Biol Psychiatry 44:1027-1036. (Pubitemid 28545231)
48. Hamilton SP, Slager SL, De Leon AB, Heiman GA, Klein DF, Hodge SE et al (2004). Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29:558-565. (Pubitemid 38365933)
49. Hart P, Farrell GC, Cooksley WG, Powell LW (1976). Enhanced drug metabolism in cigarette smokers. Br Med J 2:147-149.
50. Hawk Jr LW, Kowmas AD (2003). Affective modulation and prepulse inhibition of startle among undergraduates high and low in behavioral inhibition and approach. Psychophysiology 40:131-138. (Pubitemid 36168922)
51. Hettema JM, Neale MC, Kendler KS (2001). A review and metaanalysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158:1568-1578. (Pubitemid 32923644)
52. Hohoff C, Domschke K, Schwarte K, Spellmeyer G, Vogele C, Hetzel G et al (2009). Sympathetic activity relates to adenosine A (2A) receptor gene variation in blood-injury phobia. J Neural Transm 116:659-662.
53. Hohoff C, McDonald JM, Baune BT, Cook EH, Deckert J, de Wit H (2005). Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet 139 B: 42-44. (Pubitemid 41552296)
54. Hohoff C, Mullings EL, Heatherley SV, Freitag CM, Neumann LC, Domschke K et al (2010). Adenosine A (2A) receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 44:930-937.
55. Huang ZL, Qu WM, Eguchi N, Chen JF, Schwarzschild MA, Fredholm BB et al (2005). Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 8:858-859.
56. Jacob C, Domschke K, Gajewska A, Warrings B, Deckert J (2010). Genetics of panic disorder: focus on association studies and therapeutic perspectives. Expert Rev Neurother 10:1273-1284.
57. Jang KL, Stein MB, Taylor S, Livesley WJ (1999). Gender differences in the etiology of anxiety sensitivity: a twin study. J Gend Specif Med 2:39-44.
58. Kendler KS, Prescott CA (1999). Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry 156:223-228. (Pubitemid 29077113)
59. Koch M (1999). The neurobiology of startle. Prog Neurobiol 59:107-128. (Pubitemid 29425879)
60. Lam P, Hong CJ, Tsai SJ (2005). Association study of A2a adenosine receptor genetic polymorphism in panic disorder. Neurosci Lett 378:98-101. (Pubitemid 40354294)
61. Lang PJ (1980). Behavioral treatment and bio-behavioral assessment: computer applications. In: Sidowski JB, Johnson JH, Williams TA (eds). Technology in Mental Health Care Delivery Systems. Ablex: Norwood, NJ. pp 119-l137.
62. Lang PJ, Bradley MM, Cuthbert BN (2005). International affective picture system (IAPS): affective ratings of pictures and instruction manual. In: Technical Report A-6. University of Florida: Gainesville.
63. Lang PJ, Cuthbert BN (1984). Affective information processing and the assessment of anxiety. J Behav Assess 6:369-395. (Pubitemid 15249417)
64. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ et al (1997). Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388:674-678. (Pubitemid 27366438)
65. Lee H, Yeom H, Kim YG, Yoon CN, Jin C, Choi JS et al (1998). Structure-related inhibition of human hepatic caffeine N3-demethylation by naturally occurring flavonoids. Biochem Pharmacol 55:1369-1375. (Pubitemid 28298516)
66. Mathews A (1993). Anxiety and the processing of emotional information. Prog Exp Pers Psychopathol Res 16:254-280.
67. Mattay VS, Goldberg TE, Fera F, Hariri AR, Tessitore A, Egan MF et al (2003). Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100:6186-6191. (Pubitemid 36576952)
68. McNair D, Lorr M, Droppleman L (1992). Profile of Mood States Manual (Rev). Educational and Industrial Testing Service: San Diego.
69. Mühlberger A, Bulthoff HH, Wiedemann G, Pauli P (2007). Virtual reality for the psychophysiological assessment of phobic fear: responses during virtual tunnel driving. Psychol Assess 19:340-346. (Pubitemid 47496219)
70. Mühlberger A, Wiedemann G, Herrmann MJ, Pauli P (2006). Phylo-and ontogenetic fears and the expectation of danger: differences between spider-and flight-phobic subjects in cognitive and physiological responses to disorder-specific stimuli. J Abnorm Psychol 115:580-589. (Pubitemid 44763688)
71. Mühlberger A, Wieser MJ, Pauli P (2008). Darkness-enhanced startle responses in ecologically valid environments: a virtual tunnel driving experiment. Biol Psychol 77:47-52. (Pubitemid 350309707)
72. Nardi AE, Lopes FL, Freire RC, Veras AB, Nascimento I, Valenca AM et al (2009). Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res 169:149-153.
73. Nardi AE, Lopes FL, Valenca AM, Freire RC, Veras AB, de-Melo-Neto VL et al (2007). Caffeine challenge test in panic disorder and depression with panic attacks. Compr Psychiatry 48:257-263. (Pubitemid 46584666)
74. Nardi AE, Valenca AM, Nascimento I, Freire RC, Veras AB, de-Melo-Neto VL et al (2008). A caffeine challenge test in panic disorder patients, their healthy first-degree relatives, and healthy controls. Depress Anxiety 25:847-853.
75. Nickell PV, Uhde TW (1994). Dose-response effects of intravenous caffeine in normal volunteers. Anxiety 1:161-168.
76. Nillni YI, Toufexis DJ, Rohan KJ (2011). Anxiety sensitivity, the menstrual cycle, and panic disorder: a putative neuroendocrine and psychological interaction. Clin Psychol Rev 31:1183-1191.
77. Noschang CG, Krolow R, Pettenuzzo LF, Avila MC, Fachin A, Arcego D et al (2009). Interactions between chronic stress and chronic consumption of caffeine on the enzymatic antioxidant system. Neurochem Res 34:1568-1574.
78. Pauli P, Conzelmann A, Mucha RF, Weyers P, Baehne CG, Fallgatter AJ et al (2010). Affect-modulated startle reflex and dopamine D4 receptor gene variation. Psychophysiology 47:25-33.
79. Pauli P, Montoya P, Martz GE (1996). Covariation bias in panicprone individuals. J Abnorm Psychol 105:658-662.
80. Peterson RA, Reiss S (1992). Anxiety Sensitivity Index Manual. International Diagnostic Systems: Worthington, OH. vol. 2.
81. Powell KR, Koppelman LF, Holtzman SG (1999). Differential involvement of dopamine in mediating the discriminative stimulus effects of low and high doses of caffeine in rats. Behav Pharmacol 10:707-716. (Pubitemid 30028744)
82. Reiss S, Peterson RA, Gursky DM, McNally RJ (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24:1-8. (Pubitemid 16207745)
83. Retey JV, Adam M, Khatami R, Luhmann UF, Jung HH, Berger W et al (2007). A genetic variation in the adenosine A2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther 81:692-698. (Pubitemid 46625104)
84. Rogers PJ, Hohoff C, Heatherley SV, Mullings EL, Maxfield PJ, Evershed RP et al (2010). Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 35:1973-1983.
85. Rosen JB, Donley MP (2006). Animal studies of amygdala function in fear and uncertainty: relevance to human research. Biol Psychol 73:49-60.
86. Schicatano EJ, Blumenthal TD (1995). The effects of different doses of caffeine on habituation of the human acoustic startle reflex. Pharmacol Biochem Behav 52:231-236.
87. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al (1998). The Mini-International Neuropsychiatric Interview (M. I. N. I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59 (Suppl 20):22-33; quiz 34-57. (Pubitemid 29001829)
88. Smith GA (1988). Caffeine reduction as an adjunct to anxiety management. Br J Clin Psychol 27:265-266.
89. Toufexis DJ, Myers KM, Davis M (2006). The effect of gonadal hormones and gender on anxiety and emotional learning. Horm Behav 50:539-549. (Pubitemid 44307113)
90. Ushiroyama T, Okamoto Y, Toyoda K, Sugimoto O (1992). A case of panic disorder induced by oral contraceptive. Acta Obstet Gynecol Scand 71:78-80.
91. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG et al (1997). The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 54:305-309. (Pubitemid 27171915)
92. Wiedemann G, Pauli P, Dengler W, Lutzenberger W, Birbaumer N, Buchkremer G (1999). Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry 56:78-84. (Pubitemid 29055053)
93. Wittchen HU, Jacobi F (2005). Size and burden of mental disorders in Europe-a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol 15:357-376. (Pubitemid 40943541)
94. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jönsson B et al (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:655-679.
95. Yamada K, Hattori E, Shimizu M, Sugaya A, Shibuya H, Yoshikawa T (2001). Association studies of the cholecystokinin B receptor and A2a adenosine receptor genes in panic disorder. J Neural Transm 108:837-848. (Pubitemid 32692623)
96. Yang A, Palmer AA, de Wit H (2010). Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl) 211:245-257.
97. Yoon KL, Zinbarg RE (2007). Threat is in the eye of the beholder: social anxiety and the interpretation of ambiguous facial expressions. Behav Res Ther 45:839-847. (Pubitemid 46282613)